Lifespan Edge, a next-generation longevity clinic co-founded by futurist John Mauldin and preventive medicine pioneer Dr. Michael Roizen, has announced the opening of two new locations in West Palm Beach, Florida, and Columbia, Maryland. A third premier destination is planned for Scottsdale, Arizona. The expansion brings the clinic's concierge-style, physician-led model to new markets, combining advanced diagnostics with personalized prevention strategies to support performance, healthy aging, and long-term wellness.
The clinics offer a comprehensive approach to longevity, leveraging cutting-edge diagnostics to create individualized plans. According to the announcement, the company highlights research into Therapeutic Plasma Exchange (TPE), citing findings from the AMBAR trial that show promise in slowing aspects of cognitive and functional decline in Alzheimer's patients. Lifespan Edge emphasizes the need for further study while building what it calls the world's most comprehensive TPE database to pioneer advancements in longevity science.
John Mauldin, known for his work in economic forecasting and longevity, and Dr. Michael Roizen, a preventive medicine expert and author, founded Lifespan Edge to empower individuals through a personalized, data-driven approach to wellness. The new locations aim to make these services more accessible to residents and visitors in Florida and Maryland, with Arizona to follow.
The expansion reflects growing interest in longevity medicine, which focuses on extending healthspan rather than just lifespan. By combining concierge care with research initiatives, Lifespan Edge positions itself at the intersection of clinical practice and scientific innovation. For more details, view the full announcement including downloadable images and bios here.
Lifespan Edge’s commitment to research and innovation is central to its mission of helping individuals live longer, healthier, and more fulfilling lives. The company’s efforts to build a comprehensive TPE database could contribute to broader understanding of plasma exchange therapies for neurodegenerative conditions. While the AMBAR trial results are promising, the company stresses the importance of continued investigation.
As Lifespan Edge expands its footprint, it joins a growing number of clinics dedicated to longevity and preventive care. The new locations in West Palm Beach and Columbia are now open, with Scottsdale expected to follow. For more information, visit Lifespan Edge.
